MutantDx Technologies

The various patents have been variously combined into processes that are specific for particular clinical applications. They are listed below:

TumorPlex and ASMS

Detection of SNPs from tissue or liquid biopsy samples


Detecting mutations in small DNA fragments from tissue and liquid biopsy samples


Predicting drug efficacy for treatment with Check Point Inhibitors

RepSeqID and MSI

Detection of deletion/insertion and fusion mutations

Dr Roger Hodkinson


MutantDx Inc.

17204 106A Avenue
Edmonton, Alberta
Canada T5S 1E6